No, You Are Not Guaranteed to Develop Corporal Fibrosis
Prolonged erections from oral PDE5 inhibitors (tadalafil and sildenafil) do not automatically cause corporal fibrosis—the critical determinant is whether you experience true ischemic priapism (fully rigid erection lasting >4 hours), not simply prolonged tumescence from medication use.
Understanding the Risk Framework
The key distinction here is between prolonged erections and ischemic priapism:
- Prolonged erections (<4 hours): These are common with PDE5 inhibitors and do NOT typically progress to fibrosis 1
- Ischemic priapism (>4 hours, fully rigid): This is the condition that causes corporal fibrosis through tissue hypoxia and subsequent scarring 1
According to the 2022 AUA/SMSNA guidelines, men with prolonged erections that are not fully rigid are less likely to progress to acute ischemic priapism compared to those with fully rigid erections 1. Partial erections should not be counted toward the four-hour threshold 1.
Critical Factors That Determine Your Risk
What Protects You:
- Oral PDE5 inhibitors (your tadalafil 10 mg daily and sildenafil 60 mg) have a different risk profile than intracavernosal injections 1
- The guidelines specifically note that men treated with certain medications are less prone to progress to ischemic priapism 1
- If your erections resolve spontaneously or are not fully rigid throughout, you're at substantially lower risk
What Increases Risk:
- Fully rigid erections lasting >4 hours that don't resolve
- Pain associated with the erection (though this can be misleading) 1
- Failure to seek treatment when a true ischemic event occurs
The Fibrosis Mechanism
Corporal fibrosis develops through a specific pathophysiologic cascade:
- Prolonged ischemia (>4 hours) causes tissue hypoxia
- This triggers smooth muscle cell death and apoptosis
- Collagen deposition increases while smooth muscle content decreases
- The result is corporal veno-occlusive dysfunction 2
Importantly, research demonstrates that daily PDE5 inhibitor use actually PREVENTS fibrosis rather than causing it. A 2008 study showed that chronic daily tadalafil prevented corporal fibrosis and veno-occlusive dysfunction after cavernosal nerve injury in animal models 2. The mechanism involves maintaining cGMP levels, which preserves smooth muscle content and prevents excessive collagen deposition 2.
What You Should Do
Immediate Actions:
- Monitor erection duration carefully: If you develop a fully rigid erection lasting >4 hours, seek immediate medical attention 1
- Distinguish between partial and full rigidity: Only fully rigid erections count toward the critical 4-hour threshold 1
Risk Mitigation:
- Consider whether your current dosing is appropriate—these are relatively high doses, particularly when combined
- The FDA label for tadalafil specifically warns about prolonged erections and priapism as potential complications 3
- If you experience erections >4 hours, intracavernosal phenylephrine is the primary treatment 1
Important Caveats:
- Do not ignore warning signs: The guidelines emphasize that priapism, if not treated promptly, can result in irreversible damage to erectile tissue 3
- You should have conditions that predispose to priapism (sickle cell anemia, multiple myeloma, leukemia, anatomical penile deformities) ruled out 3
- The combination of high-dose daily tadalafil with additional sildenafil creates cumulative PDE5 inhibition that may increase risk
The Bottom Line
Your risk of fibrosis depends entirely on whether you develop true ischemic priapism, not on the mere use of oral PDE5 inhibitors. In fact, the evidence suggests daily PDE5 inhibitor therapy may be protective against fibrosis in certain contexts 2. However, your dosing regimen (10 mg tadalafil daily plus 60 mg sildenafil) is aggressive and warrants medical supervision to ensure you're not experiencing prolonged ischemic episodes that could lead to tissue damage.
The critical action is immediate medical attention if you experience a fully rigid erection lasting >4 hours 1, 3. This is the preventable event that causes fibrosis—not the medication use itself.